Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational biology, genomics and metabolomics. The platform identifies metabolic pathways that arise uniquely in cancers that enable and support their growth. These discoveries are used to develop small molecules that specifically target the reprogrammed cancer cells’ metabolism to halt their growth
|Employees (est.) (Nov 2021)||19|
Metabomed total Funding
Metabomed latest funding size
Time since last funding
|6 years ago|
|Pfizer, Boehringer Ingelheim Venture Fund, Pontifax Funds, MS Ventures, Arkin Holdings|
Who are Metabomed key executives?
Metabomed's key executives are Ali Fattaey, Andreas Goutopoulos and Aviv Sagi.
How many employees does Metabomed have?
Metabomed has 19 employees.
Who are Metabomed competitors?
Competitors of Metabomed include Galecto, Procarta Biosystems and Exo Therapeutics.
Where is Metabomed headquarters?
Metabomed headquarters is located at HaKishon St 18, Yavne.
Where are Metabomed offices?
Metabomed has offices in Yavne and Cambridge.
How many offices does Metabomed have?
Metabomed has 2 offices.
Receive alerts for 300+ data fields across thousands of companies